Renal Denervation for Controlling Hypertension Featured at EuroPCR

At this year's EuroPCR meeting in Paris, the largest European conference in the field of interventional cardiology, the topic of renal denervation (RDN) resurfaced with significant positive results from several trials across devices. The bottom line was that in these sham-controlled trials, renal denervation provided an additional therapeutic avenue for those patients who are unable to control their hypertension with lifestyle changes and medications. In all the studies presented, RDN lowered blood pressures whether the patient was on or off medications.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news